Therapeutic Core
Core Mission
The Johns Hopkins CAHN Therapeutic Core is staffed with members of Johns Hopkins Drug Discovery, seasoned experts in the field of drug discovery research with significant experience in the pharmaceutical sector. Our core was designed to complement the strength of academic research by bridging a gap between basic science and therapeutic application.
Unique Value of the Core
One of the major challenges encountered by academic institutions aiming to develop new therapeutics has been the lack of a truly dedicated drug discovery unit with expertise in a range of disciplines required for therapeutics development. To the best of our knowledge, a dedicated and experienced drug discovery unit is not integrated into any NeuroHIV center, making our core innovative and uniquely positions to drive new therapeutic development.
Core Resources
- Assay Development and Screening
- Medicinal Chemistry
- Drug Metabolism & Pharmacokinetics
- Animal Pharmacology/Toxicology
Associated Courses
- Training in Neurotherapeutics Discovery and Development for Academic Scientists
- Introduction to Drug Discovery Research
- Drug Discovery Case Studies
- Pharmaceutical Enterprise
Core Leader
Core Co-Leaders
-
Takashi Tsukamoto, PhD
- Director, Medicinal Chemistry, Johns Hopkins Drug Discovery Program
- Professor of Neurology
-
Rana Rais, PhD
- Director, Drug Metabolism and Pharmacokinetics, Johns Hopkins Drug Discovery
- Associate Professor of Neurology
Neurotherapeutics Course 2020 - Dr. Barbara Slusher
Dr. Barbara Slusher discusses the evolving role of drug discovery in academia. To illustrate, Dr. Slusher traces an example prodrug across the drug development process — from bench to bedside.
